Skip to main content

Table 1 Characteristics of breast cancer in less than 40 yrs women compared to more than 40 yrs group

From: Younger age as a prognostic indicator in breast cancer: A cohort study

Variable

Less than 40

(n = 276)

More than 40

(N = 2869)

P Value

Age in yrs (SD) #

  

< 0.001*

   Mean

35.81 (3.92)

60.08 (12.22)

 

   Median (range)

37 (20-40)

59 (41-96)

 

Tumour size (mm) #

  

0.477

   Mean

21.49

22.74

 

   Median (range)

20 (1-120)

20 (1-160)

 

Tumour grade

  

0.044*

   Grade 0

69 (27%)

697 (26.47%)

 

   Grade 1

23 (9%)

262 (9.9%)

 

   Grade 2

70 (27.3%)

912 (34.5%)

 

   Grade 3

94 (36.7%)

774 (29.3%)

 

Histology Type

  

< 0.001*

   Ductal

178 (74.2%)

1768 (72.8%)

 

   Lobular

18 (7.5%)

368 (15.2%)

 

   Others

44 (18.3%)

291(12%)

 

Tumour stage

  

0.046*

   0

17 (7.4%)

210 (9.2%)

 

   I

66 (28.6%)

538(23.6%)

 

   II

93 (40.3%)

850 (37.3%)

 

   III

46 (19.9%)

477 (20.9%)

 

   IV

9 (3.9%)

202 (8.9%)

 

ER status

  

< 0.001*

   Positive

123 (58.3%)

1629 (74.5%)

 

   Negative

88 (41.7%)

559 (25.5%)

 

PR status

  

0.319

   Positive

102 (70.3%)

1142 (72.5%)

 

   Negative

43 (29.7%)

433 (27.5%)

 

Her-2 status

  

0.002*

   Positive

34 (30.6%)

213 (18.6%)

 

   Negative

77 (69.4%)

935 (81.4%)

 

Surgical treatment

  

< 0.001*

   Mastectomy

192 (75.9%)

1647 (61.9%)

 

   BCS

61 (24.1%)

1012 (38.1%)

 

Adjuvant hormonal therapy

  

0.005*

   Yes

184 (86.4%)

2924 (92.4%)

 

   No

29 (13.6%)

159(7.6%)

 

Adjuvant chemotherapy

  

0.021*

   Yes

109 (46.2%)

866 (38.4%)

 

   No

127 (53.8%)

1389 (61.6%)

 

Adjuvant radiotherapy

  

0.778

   Yes

135 (59.2%)

1234 (58%)

 

   No

93 (40.8%)

892 (42%)

 
  1. # Mann-Whitney u test, ER = Estrogens receptor, PR = Progesterone receptor